Journal watch: Open-source papers on deck

Mar 31, 2020 Re-posted from the April 2020 issue of Vascular Specialist

The Journal of Vascular Surgery (JVS) and JVS: Venous and Lymphatic Disorders (JVS-VL) have a number of open-source articles available in the April and May issues. A sampling follows.

JVS, AprilSTABLE clinical trial on endovascular treatment of acute, complicated type B aortic dissection with a composite design device, showing favorable clinical and anatomical outcomes at 30 days and one year in the treatment of rupture and malperfusion in the setting of acute, complicated TBAD (vsweb.org/JVS-STABLE).

JVS, MayThe economic burden and clinical impact of preoperative opioid dependence for patients undergoing lower extremity bypass surgery (vsweb.org/JVSOpioidDependence); and five-year results of endovascular AAA repair with the Ovation abdominal stent graft (vsweb.org/JVS-Ovation).

JVS-VL, MayView the updated Clinical-EtiologyAnatomy-Pathophysiology (CEAP) classification system, the work of the American Venous Forum’s CEAP Task Force, created in 2017. The revision adopts the revised Delphi process. See vsweb.org/JVSVL-CEAP.

Tags
Vascular Specialist

Related Articles

Education and Representation at the Core of Inclusivity Efforts for DEI Committe

This article was published in the October issue of Vascular Specialist.

The Society for Vascular Surgery’s (SVS) Diversity, Equity, and Inclusion (DEI) Committee continues to make strides in advancing inclusivity within the organization, with several projects underway to address both ongoing challenges and new opportunities.

Why donate to the SVS PAC?

A few years ago, in his presidential address to the Midwestern Vascular Surgical Society, Mark Mattos, MD, spoke eloquently about the need to “protect our specialty.” A large part of this, he argued, is protecting our patients; no other specialty in medicine can provide the type of comprehensive vascular care that we offer. The daily reality we all face is the potential for declining Medicare reimbursement for our services.

Progress made during year like no other

While the COVID-19 pandemic and its effects dominated 2020–21 fiscal year—including the cancellation of the live 2020 Vascular Annual Meeting (VAM)—it did not deter progress on many important initiatives. “When covid hit, it intensified our focus on what was truly important: our members, their patients and the SVS as their Society,” said Executive Director Kenneth M. Slaw, PhD. “That focus was sustained the past 15 months and it has led to innovation and an unprecedented volume of member value programs.” He outlined important highlights from the fiscal year that ended March 31—just more than a year after the pandemic was declared—and the vital initiatives that continue to move forward.